# Anti-NY-ESO-1 Immunotherapeutic GSK-2241658A

National Cancer Institute

## Source

National Cancer Institute. Anti-NY-ESO-1 Immunotherapeutic GSK-2241658A, NCI Thesaurus. Code C116847.

An immunotherapeutic agent targeting the tumor-associated antigen (TAA), cancer/testis antigen NY-ESO-1, with potential antineoplastic activity.